RA Capital Management’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-336,843
Closed -$532K 95
2024
Q4
$532K Sell
336,843
-429,991
-56% -$661K 0.01% 88
2024
Q3
$1.2M Sell
766,834
-5,483,166
-88% -$9.07M 0.01% 80
2024
Q2
$11.2M Hold
6,250,000
0.15% 65
2024
Q1
$18M Buy
+6,250,000
New +$10.2M 0.23% 66
2016
Q2
Sell
-8,709
Closed -$7.24M 37
2016
Q1
$7.24M Sell
8,709
-20,315
-70% -$16.2M 0.93% 28
2015
Q4
$30.4M Sell
29,024
-4,641
-14% -$4.65M 3.01% 10
2015
Q3
$26.4M Buy
33,665
+2,078
+7% +$2.13M 3.79% 6
2015
Q2
$41.5M Buy
31,587
+1,665
+6% +$2.69M 4.18% 6
2015
Q1
$60.8M Sell
29,922
-9,602
-24% -$20.9M 6.04% 5
2014
Q4
$76.1M Buy
+39,524
New +$70.3M 8.18% 4

Other funds holding RGLS